In this study, we show that the hypoxic microenvironment of a tumor is resistant to mTOR inhibitors, and we propose that targeting the hypoxic region of a tumor is an effective approach to enhance their anti-tumor efficacy. The gene discussed is MTOR; the disease is neoplasm.